Going Back to the Biology of FGF21: New Insights, 2019, Lewis et al

Discussion in 'Other health news and research' started by SNT Gatchaman, Apr 30, 2022.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,571
    Location:
    Aotearoa New Zealand
    Going Back to the Biology of FGF21: New Insights
    Jo E. Lewis, Francis J.P. Ebling, Ricardo J. Samms, Kostas Tsintzas

    Fibroblast growth factor 21 (FGF21) is a protein highly synthesized in the liver that exerts paracrine and endocrine control of many aspects of energy homeostasis in multiple tissues. In preclinical models of obesity and type 2 diabetes, treatment with FGF21 improves glucose homeostasis and promotes weight loss, and, as a result, FGF21 has attracted considerable attention as a therapeutic agent for the treatment of metabolic syndrome in humans. An improved understanding of the biological role of FGF21 may help to explain why its therapeutic potential in humans has not been fully realized. This review will cover the complexities in FGF21 biology in rodents and humans, with emphasis on its role in protection from central and peripheral facets of obesity.

    Link (Paywalled)
     
    Michelle, Trish and Hutan like this.
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,571
    Location:
    Aotearoa New Zealand
    Some quotes, as the article is pay-walled —

     
    Michelle and Hutan like this.

Share This Page